With 2 mL bacteriostatic water
10.0 units
Page last checked
Reconstitution · Selank
Pick the vial, the water you added and the dose. Get the exact draw in units for the syringe in your hand.
Step 1 of 4
This vial holds 10,000 mcg in total.
U-100 insulin syringe · 1 mL · lines every 2 units · 1 unit = 0.01 mL
15.0 units on a U-100 insulin syringe · 1 mL · lines every 2 units, which is 0.15 milliliters. The nearest syringe line is 16 units.
Your address is used to send this one card. The email also includes an optional link for updates when our data changes. Nothing else is sent unless you choose that link, and you can unsubscribe anytime.
Selank is a peptide seven amino acids long. It is a small immune fragment called tuftsin, with a tail added to slow its breakdown. Sellers market it for anxiety, stress and calm focus.
Russian groups gave it to patients with anxiety disorders and compared it with two older sedatives. Those studies never said how much anyone received. No source gives a human dose. English reviews describe it as well tolerated, but they trace that claim to an experiment in rats.
No completed controlled human trial has shown which dose works for Selank. There is no study-backed human dosing program to publish. Animal quantities are not converted into a human recommendation.
no human dose shown to work
Each row uses 10 mg and the liquid volume shown. Dividing the amount by that volume gives the calculated concentration. The rows are arithmetic examples, not alternative product preparations.
With 2 mL bacteriostatic water
10.0 units
With 3 mL bacteriostatic water
15.0 units
| Bacteriostatic water | Concentration | Per U-100 unit | Draw for 500 mcg | Nearest syringe line |
|---|---|---|---|---|
| 2 mL | 5.00 mg/mL | 50.0 mcg | 10.0 u · 0.100 mL | exactly 10 u |
| 3 mL | 3.33 mg/mL | 33.3 mcg | 15.0 u · 0.150 mL | 16 u · 6.7% off |
The amount, liquid volume and dose shown here are the calculator’s starting example for Selank. Replace them with your own values. Every result in the table is calculated from those inputs.
The cited abstracts report anxiety studies but omit the amount given. They describe outcomes that can be read and compared. They do not provide enough detail to set a supported dose or reproduce the treatment.
One study compared Selank with medazepam in people with generalized anxiety and neurasthenia. Researchers tracked symptoms using the Hamilton and Zung scales, plus a clinician’s global rating. They also measured a blood marker linked to the body’s enkephalins. These were outcome measures; they did not define an injection schedule.
The researchers reported similar effects on anxiety, with some other effects differing between the groups. A comparison with an active medicine does not tell us how either group would have done with placebo.
The phenazepam comparison included people with anxiety and somatoform disorders. Its abstract reports reduced anxiety and better quality of life. It also describes an effect lasting after treatment ended. These are the authors’ reported findings in those patients, not proof of the same effects in healthy people or with an injected preparation.
Neither abstract states the dose. The amount, route and full method would need to be checked before treating either report as a usable protocol. A sample value in the calculator only shows how mass, concentration and liquid volume relate. A precise syringe reading cannot supply the clinical details missing from a study record.
One study compared Selank with medazepam in people with generalized anxiety and neurasthenia. Researchers tracked symptoms using the Hamilton and Zung scales, plus a clinician’s global rating. They also measured a blood marker linked to the body’s enkephalins. These were outcome measures; they did not define an injection schedule.
The researchers reported similar effects on anxiety, with some other effects differing between the groups. A comparison with an active medicine does not tell us how either group would have done with placebo.
The phenazepam comparison included people with anxiety and somatoform disorders. Its abstract reports reduced anxiety and better quality of life. It also describes an effect lasting after treatment ended. These are the authors’ reported findings in those patients, not proof of the same effects in healthy people or with an injected preparation.
Neither abstract states the dose. The amount, route and full method would need to be checked before treating either report as a usable protocol. A sample value in the calculator only shows how mass, concentration and liquid volume relate. A precise syringe reading cannot supply the clinical details missing from a study record.
Mix 10 mg into 3 mL and one U-100 unit carries 33.3 mcg. The table shows how much peptide is in each numbered syringe line. These are conversion examples, not suggested doses.
| U-100 line | Volume | Mass (mcg) | Mass (mg) |
|---|---|---|---|
| 10 u | 0.10 mL | 333 mcg | 0.333 mg |
| 20 u | 0.20 mL | 667 mcg | 0.667 mg |
| 30 u | 0.30 mL | 1,000 mcg | 1 mg |
| 40 u | 0.40 mL | 1,333 mcg | 1.333 mg |
| 50 u | 0.50 mL | 1,667 mcg | 1.667 mg |
| 60 u | 0.60 mL | 2,000 mcg | 2 mg |
| 70 u | 0.70 mL | 2,333 mcg | 2.333 mg |
| 80 u | 0.80 mL | 2,667 mcg | 2.667 mg |
| 90 u | 0.90 mL | 3,000 mcg | 3 mg |
| 100 u | 1.00 mL | 3,333 mcg | 3.333 mg |
The math is only one part of the question. These guides cover the compound, published doses, side effects, mixing steps and supplies.